Home
About
Contact
DISCLAIMER: This site is for informational purposes only. While we make every effort to keep it up to date, there is no guarantee that information is complete, accurate, comprehensive, or the same for all KP regions. The information on this site should not be interpreted or used as a substitute for professional medical care. Please consult your care provider for any personal health questions or before participating in clinical trials.
Search Results
Tip
Select Recruitment Status
Active, not yet recruiting
Active, currently enrolling
Active, enrolling only by invitation
Enrollment complete
Study completed
Enrollment on hold
Study terminated early
Select Study Type
INTERVENTIONAL
OBSERVATIONAL
Select Clinical Trial Type
Phase I
Phase II
Phase IIA
Phase IIB
Phase III
Phase IV
n/a
Select Clinical Area
Adolescent Medicine
Addiction Medicine
Allergy and Immunology
Anesthesiology
Cardiology
Complimentary and Alternative Med
Dermatology
Emergency Medicine
Endocrinology, Diabetes and Metabolism
Epidemiology
Family Medicine
Genetics
Geriatric Medicine
Gastroenterology
Hematology
Infectious Diseases
Internal Medicine
Nephrology
Lifestyle Medicine
Neurology/Neurological Disorders
Nuclear Medicine
Nursing
Obstetrics and Gynecology
Occupational Medicine
Oncology (Adult)
Oncology (Pediatrics)
Ophthalmology
Other
Otolaryngology/ENT
Pediatrics
Physical Medicine and Rehabilitation
Podiatric Medicine
Preventative Medicine
Psychiatry
Pulmonary Disease
Radiology
Rheumatology
Sports Medicine
Surgery (Colon and Rectal)
Surgery (General)
Surgery (Hand)
Surgery (Neurological)
Surgery (Orthopedic)
Surgery (Plastic)
Surgery (Thoracic)
Surgery (Urology)
Surgery (Vascular)
Urology
Select Regions
California - Northern
California - Southern
Colorado
Georgia
Hawaii
Mid-Atlantic
Northwest
Washington
Select Facility 1
Select Facility 2
Select Facility 3
Male
Female
Child (Birth - 17 yrs)
Adult (18 - 65 yrs)
Senior (66 and above)
Saved Studies
You currently don’t have any saved studies. To save a study, select the bookmark icon on the result listing.
Active, currently enrolling
Who can join
Connect for Cancer Prevention Study: A Prospective Cohort Study Within Integrated Healthcare Systems in the US
Keywords:
Risk Factors; Medical Conditions; Pathology; Blood; Urine; Natural History
Study Type:
Prospective Cohort Study with Direct Patient Contact |
Region:
Georgia
Enrollment complete
Who can join
A Prospective Observational Cohort Study to Assess miRNA 371 for Outcome Prediction in Patients With Newly Diagnosed Germ Cell Tumors
Keywords:
Oncology (Adult);Other;
Study Type:
Clinical Trial |
Region:
California - Northern
Active, currently enrolling
Who can join
A Phase 1b/2, Randomized, Open-Label Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy in Patients With Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer
Keywords:
Oncology (Adult);Gastroenterology;
Study Type:
Clinical Trial |
Region:
California - Northern
Active, currently enrolling
Who can join
OptimICE-pCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy
Keywords:
Obstetrics and Gynecology;Oncology (Adult);
Study Type:
Clinical Trial |
Region:
Colorado
Enrollment complete
Who can join
Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: A Phase III Study
Keywords:
Oncology (Adult);Obstetrics and Gynecology;
Study Type:
Clinical Trial |
Region:
California - Northern
Enrollment complete
Who can join
Intergroup Randomized Phase 2 Four Arm Study In Patients = 60 With Previously Untreated Mantle Cell Lymphoma Of Therapy With: Arm A = Rituximab+ Bendamustine Followed By Rituximab Consolidation (RB ? R); Arm B = Rituximab + Bendamustine + Bortezomib Followed By Rituximab Consolidation (RBV? R), Arm C = Rituximab + Bendamustine Followed By Lenalidomide + Rituximab Consolidation (RB ? LR) or Arm D
Keywords:
Oncology (Adult); E1411; neurotoxicity; therapy-related toxicity; contiguous…
Study Type:
Clinical Trial |
Region:
California - Northern
Enrollment complete
Who can join
A Randomized Phase III Study of Ibrutinib (PCI-32765)-Based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)
Keywords:
Oncology (Adult);Allergy and Immunology;Hematology;
Study Type:
Clinical Trial |
Region:
Colorado
Enrollment complete
Who can join
Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma
Keywords:
Oncology (Adult);Allergy and Immunology;Hematology;
Study Type:
Clinical Trial |
Region:
Colorado
Active, currently enrolling
Who can join
A Phase 3 Open-Label, Randomized, Controlled, Global Study of Telisotuzumab Vedotin (ABBV-399) Versus Docetaxel in Subjects with Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer
Keywords:
Oncology (Adult);
Study Type:
Clinical Trial |
Region:
Hawaii
Enrollment on hold
Who can join
The Association of Breast Density Changes, Plasma Hormone Changes, and Breast Cancer Recurrence: A Companion Study to NCIC CTG MA.27
Keywords:
Oncology (Adult);Obstetrics and Gynecology; stage I breast cancer, stage II…
Study Type:
Other Observational Study with Direct Patient Contact |
Region:
California - Northern
1
2
3
4
5
6
7
8
9
10
...